Form D · Pharmaceuticals
Tribute Pharmaceuticals Canada Inc.
Milton, A6 · CIK 0001159019
Offering snapshot reported Feb 5, 2016 · SEC filing
- Reported sold
- $75M Offering amount: $75M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 5, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 5, 2016 | Initial | $75,000,000 | No comparison | 3 | SEC filing |
| Feb 5, 2016 | Initial | $75,000,000 | No comparison | 7 | SEC filing |
| Jun 10, 2015 | Amendment | Yet to sell | No comparison | 2 | SEC filing |
| Jun 5, 2015 | Initial | $4,098,025 | No comparison | 2 | SEC filing |
| Oct 21, 2014 | Initial | Yet to sell | No comparison | 13 | SEC filing |
| Oct 21, 2014 | Initial | $0 | No comparison | 1 | SEC filing |
| Oct 21, 2014 | Initial | Yet to sell | No comparison | 2 | SEC filing |
| Mar 18, 2013 | Initial | $4,270,000 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-256901
Each convertible note bears interest at 2.5% for up to 6 years with at the Conversion Price defined in the Second Amended and Restated Facility Agreement dated December 7, 2015.
Source: Form D, filed Feb 5, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Scott J. Charles | Director |
| Bernard Chiasson | Executive |
| Janice M. Clarke | Executive |
| Steven H Goldman | Director |
| John M Gregory | Director |
| Robert Gregory | Director |
| Robert Harris | Director |
| John J Kime | Director |
| Andrew I. Koven | Director, Executive |
| Scott Langille | Director, Executive |
| Murray Roach | Executive |
| Arnold Tenney | Director |
| F Martin Thrasher | Director |
| F. Martin Thrasher | Director |
| Eric L. Trachtenberg | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
151 Steeles Avenue East
Milton, A6, L9T 1Y1
Milton, A6, L9T 1Y1